An important training initiative dedicated to the use of artificial intelligence in the field of biomedical research. The event, aimed at PhD students of the PhD programs in Clinical and Experimental Medicine (Coordinator Prof. Marco Vinceti), Neuroscience (Coordinator Prof. Sandro Rubichi) and Molecular and Regenerative Medicine (Coordinator Prof. Michele De Luca) , will offer the opportunity to delve into the latest trends and challenges in the field of AI applied to biomedical research.

The use of AI also in the medical field is in fact becoming increasingly widespread, thanks to the numerous applications it offers, such as medical diagnosis, personalization of therapy and research in the biomedical field itself. However, the adoption of artificial intelligence also poses several ethical challenges, such as the need to ensure patient data privacy, medical and professional liability, and interactions and possible conflicts between human and AI competencies.

The initiative will see the participation as speakers of industry experts with particular expertise in the application of AI to the biomedical field and research, who will share their experience and provide a complete picture on the potential and limits of AI in this field.

The event represents a precious opportunity for doctoral students of the University of Modena and Reggio Emilia to explore the topic of AI applied to medicine and to acquire knowledge and skills useful for their future career.

Prof. Vinceti commented in this regard: “The training initiatives of the UNIMORE doctorates in the biomedical area continue and are strengthened thanks to their close collaboration, for which I thank my colleagues Prof. De Luca and Prof. Rubichi, Prof. Manfredini, and the General Manager Ing. Chiantore, with a view to adapting to recent ministerial indications but above all to the emerging challenges in the scientific and application fields. Particularly qualified speakers will illustrate to our PhD students highly topical topics of AI in the biomedical field: from the role of the so-called ‘GPT Transformers’ such as chatGPT to the use of AI in Evidence Management and in Scientific Literature Reviews within the European Authority EFSA, from the Italian strategy for the Digital Brain Research Action to the use of AI in radiology and neuroimaging. Finally, specific attention will be dedicated to the delicate ethical aspects that the growing use of AI is placing in the biomedical field“.

CEM seminar on Artificial and Biomedical Intelligence